Showing results (1801-1810 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|July 1, 2025
Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humansChiara Lattanzi, Francisco Bianchetto-Aguilera, Marta Donini, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Oncoimmunology|August 2, 2025
Systematic identification of lincRNA-derived immunogenic peptides in melanomaEmilie Dupré, Amélie Guiho, Tiffany Beauvais, et al.
Oncoimmunology|August 18, 2025
CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183-91/HLA-A *0201 exhibit potent activity against HBV-HCCFengling Wang, Jiaqian Li, Yong Huang, et al.
Oncoimmunology|August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophagesKatherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Oncoimmunology|November 17, 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cellsNiels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
Oncoimmunology|November 17, 2022
Spermidine rejuvenates T lymphocytes and restores anticancer immunosurveillance in aged miceFrancesca Castoldi, Guido Kroemer, Federico Pietrocola
Oncoimmunology|April 15, 2025
Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancerFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
Pageof 380